AJMCtv interviews let you catch up with experts on what's new and important about the changes in healthcare. Where else can a few minutes of your time give you insights from key decision makers - from the clinician, to the health plan leader, to the regulator? AJMCtv interviews give you the close-ups you might not get even if you make it to the conference. When every minute in your day matters, AJMCtv interviews keep you informed.
Only about one-fourth of all patients with behavioral health issues are diagnosed by a primary care provider and receive the appropriate treatment, said Paul Ciechanowski, MD, MPH.
Although hospital consolidation has not shown the benefits proponents had touted, it is inevitable that there will be consolidation in healthcare, because the environment is too challenging for smaller hospitals and many physician practices, explained Paul Ginsburg, PhD.
While the shift to cancer becoming more of a chronic disease does not have a huge change on the approach of the payer, there are some new challenges to address, said Jennifer Malin, MD, medical director for oncology at Anthem.
Patient engagement is in constant change and has evolved over the years into how care is delivered and how quality measures are developed, explained Marc Boutin, JD, chief executive officer
It’s time for employers to consider more than just the medical benefits but the pharmacy benefits when it comes to specialty pharmaceuticals, said Cheryl Larson, BA, vice president of the Midwest Business Group on Health.
Restrictive prior authorization policies have made had a negative impact on schizophrenia patients, who tend to be an already-difficult population to treat, explained Dana Goldman, PhD.
The field of managed care has evolved greatly over the last 20 years, and The American Journal of Managed Care has kept those in the industry up to date with changes, said Risa Lavizzo-Mourey, MD, MBA, president and CEO of the Robert Wood Johnson Foundation.
While health information technology can be a solution for primary medication nonadherence, it can also be burdensome, according to Lauren Harner, JD, senior manager of policy at PhRMA.